These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 2380644)

  • 21. Postmortem diagnosis of diabetes mellitus. Quantitation of fructosamine and glycated hemoglobin.
    Valenzuela A
    Forensic Sci Int; 1988 Sep; 38(3-4):203-8. PubMed ID: 3192143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The value of fructosamine in the screening and evaluation of the metabolic control of the diabetic patient].
    Veillon H; Rieder A; Stara B; Darioli R
    Schweiz Rundsch Med Prax; 1988 May; 77(22):613-7. PubMed ID: 3387756
    [No Abstract]   [Full Text] [Related]  

  • 23. [Levels of fasting blood glucose and serum fructosamine for monitoring of glucose control in patients with non-insulin-dependent diabetes mellitus].
    Mercelina LF; Degenaar CP; Nieuwenhuijzen Kruseman AC
    Ned Tijdschr Geneeskd; 1989 Sep; 133(38):1887-90. PubMed ID: 2797305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum fructosamine assay in the evaluation and follow-up of diabetics].
    Shapiro MS; Ludvinovsky S; Weiss E; Arber I
    Harefuah; 1990 Apr; 118(8):447-9. PubMed ID: 2358226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fructosamine assay: an index of medium-term metabolic control parameters in diabetic disease.
    Lapolla A; Poli T; Barison A; Fedele D
    Diabetes Res Clin Pract; 1988 Feb; 4(3):231-5. PubMed ID: 3359924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening.
    Tsuji I; Nakamoto K; Hasegawa T; Hisashige A; Inawashiro H; Fukao A; Hisamichi S
    Diabetes Care; 1991 Nov; 14(11):1075-7. PubMed ID: 1797489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of serum fructosamine as a measure of glycemia in young and old diabetic and non-diabetic subjects.
    Negoro H; Morley JE; Rosenthal MJ
    Am J Med; 1988 Sep; 85(3):360-4. PubMed ID: 3414731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum fructosamine: a parameter for monitoring metabolic control in diabetes.
    Gomo Z
    Cent Afr J Med; 1992 Sep; 38(9):358-62. PubMed ID: 1298563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fructosamine and glycated hemoglobin as indices of glycemic control in patients with liver cirrhosis.
    Trenti T; Cristani A; Cioni G; Pentore R; Mussini C; Ventura E
    Ric Clin Lab; 1990; 20(4):261-7. PubMed ID: 2075378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of fructosamine and glycated haemoglobin to verify self blood glucose monitoring data in diabetic pregnancy.
    Parfitt VJ; Clark JD; Turner GM; Hartog M
    Diabet Med; 1993 Mar; 10(2):162-6. PubMed ID: 8458194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lipoprotein and apolipoprotein levels in young insulin-dependent diabetic patients. Relations with glycosylated hemoglobin and fructosamine].
    Willems D; Dorchy H
    Presse Med; 1990 Jan 6-13; 19(1):17-20. PubMed ID: 2137219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The why and wherefore of fructosamine.
    Mendlovic DB; Whitehouse FW; Foreback CC
    Henry Ford Hosp Med J; 1992; 40(1-2):149-51. PubMed ID: 1428970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity of serum fructosamine in short term glycemic control.
    Prior TW; Chapman JF; Bankson DD
    Ann Clin Lab Sci; 1989; 19(2):107-13. PubMed ID: 2751240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum fructosamine in patients with diabetes mellitus.
    Baker J; Reid I; Holdaway I
    N Z Med J; 1985 Jul; 98(782):532-5. PubMed ID: 3861965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum fructosamine level as a marker of glycemic control in diabetic patients with and without a residual C-peptide secretion.
    Buysschaert M; Ketelslegers JM; Mpoy M; Galanti L; Pirson F; Pouthier F; Lambert AE
    Diabetes Res; 1987 Nov; 6(3):129-31. PubMed ID: 3436113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New diagnostic tests for diabetes mellitus. Hemoglobin A1 (A1c) and fructosamine].
    Okuda Y; Itakura M; Yamashita K
    Nihon Rinsho; 1989 Nov; 47(11):2467-71. PubMed ID: 2601058
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical utility of serum fructosamine in diabetes mellitus compared with hemoglobin A1c.
    Jerntorp P; Sundkvist G; Fex G; Jeppsson JO
    Clin Chim Acta; 1988 Jul; 175(2):135-42. PubMed ID: 3409529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Routine control of type 2 diabetes. Are glycosylated hemoglobin and fructosamine measurements necessary?].
    Tryggeseth A
    Tidsskr Nor Laegeforen; 1990 Aug; 110(19):2539-40. PubMed ID: 2219017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of HbA1 and fructosamine in predicting impaired glucose tolerance--an alternative to OGTT to detect diabetes mellitus or gestational diabetes.
    Salemans TH; van Dieijen-Visser MP; Brombacher PJ
    Ann Clin Biochem; 1987 Sep; 24 ( Pt 5)():447-52. PubMed ID: 3662394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical utility of assays of glycosylated haemoglobin and serum fructosamine compared: use of data on biological variation.
    Howey JE; Bennet WM; Browning MC; Jung RT; Fraser CG
    Diabet Med; 1989 Dec; 6(9):793-6. PubMed ID: 2533039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.